gtbp_nt10k
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check
One)
[X]
Form 10-K [_] Form
20-F [_] Form 11-K
[_] Form 10-Q [_] Form
10-D [_] Form N-SAR
[_] N-CSR
For
Period Ended: December 31,
2020
[_]
Transition Report on Form 10-K
[_]
Transition Report on Form 20-F
[_]
Transition Report on Form 11-K
[_]
Transition Report on Form 10-Q
[_]
Transition Report on Form N-SAR
For the
Transition Period Ended: ________________________
Read Instruction (on back page) Before Preparing Form. Please Print
or Type.
Nothing in this form shall be construed to imply that the
Commission has verified any information contained
herein.
|
If the
notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification
relates:
PART I
- REGISTRANT INFORMATION
Full
Name of Registrant:
Former
Name if Applicable
9350 Wilshire Blvd. Suite
203
Address
of Principal Executive Office (Street and Number)
City,
State and Zip Code
PART II - RULES 12b-25 (b) AND (c)
If the
subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the following should be completed. (Check box if
appropriate)
[X]
|
(a)
|
The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or
expense;
|
[X]
|
(b)
|
The subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, 11-K, Form N-CEN or Form N-CSR, or portion
thereof, will be filed on or before the fifteenth calendar day
following the prescribed due date; or the subject quarterly report
of transition report on Form 10-Q or subject distribution report on
Form 10-D, or portion thereof will be filed on or before the fifth
calendar day following the prescribed due date; and
|
|
(c)
|
The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
|
PART III - NARRATIVE
State
below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K,
10-Q, 10-D, N-SAR, N-CSR or the transition report or portion
thereof could not be filed within the prescribed time
period.
The
Registrant is unable to file the subject report in a timely manner
because the Registrant was not able to complete timely its internal
processes necessary for management to certify its financial
statements without unreasonable effort or expense. The Registrant
expects to file within the extension period.
PART IV - OTHER INFORMATION
(1)
Name and telephone number of person to contact in regard to this
notification:
Michael Handelman
|
|
805
|
|
341-2631
|
(Name)
|
|
(Area Code)
|
|
(Telephone No.)
|
(2)
Have all other periodic reports required under section 13 or 15(d)
of the Securities Exchange Act of 1934 or Section 30 of the
Investment Company Act of 1940 during the preceding 12 months or
for such shorter period that the registrant was required to file
such report(s) been filed? If the answer is no, identify report(s).
[X] Yes [_] No
(3) Is
it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject
report or portion thereof? [_] Yes [X] No
If so,
attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
GT Biopharma, Inc.
(Name
of Registrant as Specified in Charter)
has
caused this notification to be signed on its behalf by the
undersigned thereunto duly authorized.
Dated:
March 31, 2021
|
GT
Biopharma, Inc.
By: /s/
Michael Handelman
Michael
Handelman
Chief
Financial Officer
|